Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Cephalosporin Drugs Market to reach USD XX billion by the end of 2030

Global Cephalosporin Drugs Market Size Study & Forecast, by Generation (First-generation, Second-generation, Third-generation, Fourth-generation, Fifth-generation), by Prescription (Prescription Drugs, OTC Drugs), and Regional Analysis, 2023-2030

Product Code: HLSDT-52756692
Publish Date: 10-03-2024
Page: 200

Global Cephalosporin Drugs Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than 2.75% during the forecast period 2023-2030. Cephalosporin, a versatile β-lactam antibiotic with a broad spectrum, is derived from the fungus Acremonium. It is primarily employed for treating a wide range of bacterial infections, such as skin infections, otitis media, pneumonia, staph infections, tonsillitis, strep throat, bronchitis, and gonorrhea, serving both therapeutic and preventive purposes. First-generation cephalosporins are particularly effective against gram-positive bacteria such as Staphylococcus and Streptococcus, playing a crucial role in preventing hospital-acquired infections and treating skin and soft tissue infections. In contrast, second to fifth-generation drugs are specifically designed to combat gram-negative bacteria. These medications are also used in managing drug-induced allergic conditions, particularly in individuals with penicillin allergies. The Cephalosporin Drugs Market is expanding because of factors such as the increasing prevalence of infectious diseases, rise in government initiatives and healthcare policies, growing funding for the development of antibiotics, and expanding access to healthcare services.

In addition, the market is fueled by escalating demand for antimicrobials across various medical conditions, the surge in infectious diseases such as HIV and tuberculosis, and augmented funding for antibiotic research and development. For instance, the World Health Organization’s October 2021 report highlighted tuberculosis as a global concern, with approximately 10 million reported cases in 2020, concentrated heavily in eight countries including India, China, and Indonesia. Additionally, a rapid spread of infectious diseases, as evidenced by a World Health Organization survey conducted from January 24 to February 6, 2022, recorded around 12,368 cases of influenza viruses. This surge highlights the growing need for cephalosporins to address infectious diseases, contributing to market growth. The increased consumption of cephalosporins, coupled with their widespread availability and the rising demand for over-the-counter medications, further drives market expansion. Thus, these aforementioned factors are propelling the growth of the Cephalosporin Drugs Market during the estimated period. Moreover, the advancements in drug development activities, as well as the surge in demand for anti-microbials in various indications present various lucrative opportunities over the forecast years. However, the stringent regulatory guidelines, along with side effects associated with cephalosporin are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Cephalosporin Drugs Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the escalating infectious disease rates, growing healthcare spending, and a sizable population, availability of advanced healthcare infrastructure and skilled medical professionals. According to the Center for Disease Control and Prevention (CDC), in 2020, the United States recorded approximately 7,174 new tuberculosis cases, reflecting a rate of 2.2 per 100,000 individuals, highlighting a significant concern. Consequently, the mounting burden of infectious diseases is expected to propel market expansion. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The increasing number of surgical procedures, hospitalizations, and healthcare-associated infections, the growing geriatric population, and favorable government initiatives to combat antimicrobial resistance are significantly propelling the market demand across the region.

Major market players included in this report are:
Baxter International Inc.
F. Hoffmann-La Roche Ltd
GlaxoSmithKline PLC
Lupin Pharmaceuticals Inc.
Macleods Pharmaceuticals Ltd
Mankind Pharma Ltd.
Merck & Co. Inc
Pfizer Inc.
Teva Pharmaceutical Industries Ltd
Bristol-Myers Squibb Company

Recent Developments in the Market:
Ø In March 2023, Hikma Pharmaceuticals PLC (Hikma) introduced Cefazolin injection to treat a range of bacterial infections, including those affecting the joints, skin, blood, bone, and genitalia.
Ø In July 2022, Mast introduced Ceftobiprole 5µg to its MASTDISCS Antimicrobial Susceptibility Test range. Ceftobiprole (Zevtera/Mabelio) is a 5th generation Cephalosporin with broad-spectrum capabilities, approved in various European countries for treating Community Acquired Pneumonia (CAP) and Hospital-Acquired Pneumonia (HAP). With potent activity against Methicillin Resistant Staphylococcus aureus (MRSA) and a favorable safety profile, Ceftobiprole is a valuable option for targeted empirical therapy
Ø In June 2022, Shionogi & Co., Ltd., GARDP, and the Clinton Health Access Initiative (CHAI) signed a collaborative agreement to increase access to cefiderocol in over 70% of nations globally. This deal should broaden the company’s product offering internationally and enhance income generation.

Global Cephalosporin Drugs Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Generation, Prescription, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Generation:
First-generation
Second-generation
Third-generation
Fourth-generation
Fifth-generation

By Prescription:
Prescription Drugs
OTC Drugs

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Cephalosporin Drugs Market, by Region, 2020-2030 (USD Billion)
1.2.2. Cephalosporin Drugs Market, by Generation, 2020-2030 (USD Billion)
1.2.3. Cephalosporin Drugs Market, by Prescription, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cephalosporin Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cephalosporin Drugs Market Dynamics
3.1. Cephalosporin Drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing government initiatives and favourable healthcare policies
3.1.1.2. Rising demand for antimicrobials across various medical conditions
3.1.2. Market Challenges
3.1.2.1. Stringent regulatory guideline
3.1.2.2. Side effects associated with cephalosporin
3.1.3. Market Opportunities
3.1.3.1. Advancements in drug development activities
3.1.3.2. Surge in demand for anti-microbials in various indications
Chapter 4. Global Cephalosporin Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Cephalosporin Drugs Market, by Generation
5.1. Market Snapshot
5.2. Global Cephalosporin Drugs Market by Generation, Performance – Potential Analysis
5.3. Global Cephalosporin Drugs Market Estimates & Forecasts by Generation 2020-2030 (USD Billion)
5.4. Cephalosporin Drugs Market, Sub Segment Analysis
5.4.1. First-generation
5.4.2. Second-generation
5.4.3. Third-generation
5.4.4. Fourth-generation
5.4.5. Fifth-generation
Chapter 6. Global Cephalosporin Drugs Market, by Prescription
6.1. Market Snapshot
6.2. Global Cephalosporin Drugs Market by Prescription, Performance – Potential Analysis
6.3. Global Cephalosporin Drugs Market Estimates & Forecasts by Prescription 2020-2030 (USD Billion)
6.4. Cephalosporin Drugs Market, Sub Segment Analysis
6.4.1. Prescription Drugs
6.4.2. OTC Drugs
Chapter 7. Global Cephalosporin Drugs Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Cephalosporin Drugs Market, Regional Market Snapshot
7.4. North America Cephalosporin Drugs Market
7.4.1. U.S. Cephalosporin Drugs Market
7.4.1.1. Generation breakdown estimates & forecasts, 2020-2030
7.4.1.2. Prescription breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Cephalosporin Drugs Market
7.5. Europe Cephalosporin Drugs Market Snapshot
7.5.1. U.K. Cephalosporin Drugs Market
7.5.2. Germany Cephalosporin Drugs Market
7.5.3. France Cephalosporin Drugs Market
7.5.4. Spain Cephalosporin Drugs Market
7.5.5. Italy Cephalosporin Drugs Market
7.5.6. Rest of Europe Cephalosporin Drugs Market
7.6. Asia-Pacific Cephalosporin Drugs Market Snapshot
7.6.1. China Cephalosporin Drugs Market
7.6.2. India Cephalosporin Drugs Market
7.6.3. Japan Cephalosporin Drugs Market
7.6.4. Australia Cephalosporin Drugs Market
7.6.5. South Korea Cephalosporin Drugs Market
7.6.6. Rest of Asia Pacific Cephalosporin Drugs Market
7.7. Latin America Cephalosporin Drugs Market Snapshot
7.7.1. Brazil Cephalosporin Drugs Market
7.7.2. Mexico Cephalosporin Drugs Market
7.8. Middle East & Africa Cephalosporin Drugs Market
7.8.1. Saudi Arabia Cephalosporin Drugs Market
7.8.2. South Africa Cephalosporin Drugs Market
7.8.3. Rest of Middle East & Africa Cephalosporin Drugs Market

Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Baxter International Inc.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. F. Hoffmann-La Roche Ltd
8.3.3. GlaxoSmithKline PLC
8.3.4. Lupin Pharmaceuticals Inc.
8.3.5. Macleods Pharmaceuticals Ltd
8.3.6. Mankind Pharma Ltd.
8.3.7. Merck & Co. Inc
8.3.8. Pfizer Inc.
8.3.9. Teva Pharmaceutical Industries Ltd
8.3.10. Bristol-Myers Squibb Company
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now